Analysis of Glycemic Control in Type 1 Diabetes Patients Using Hybrid Closed Loop Insulin Pump Therapy (Medtronic 670G)
NCT ID: NCT04051632
Last Updated: 2019-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
96 participants
OBSERVATIONAL
2018-06-13
2019-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Glycemic Outcomes and Safety With Minimed 780G System in Children With Type 1 Diabetes Aged 2-6 Years
NCT04949022
Closed-Loop Insulin Delivery in Children Less Than 7 Years of Age
NCT01421225
Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes
NCT02463097
Medtronic 670G Insulin Pump and the Impact on Glycemic Control, Quality of Life, and Compliance
NCT04329871
Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes
NCT02660827
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Major outcome measure was to assess the percent of patients who were able to successfully continue to use the 670G technology over time.
Additional outcome variables included hemoglobin A1c pre and post treatment with the 670G, time in desired glucose range 70-180.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Type 1 Diabetes patients treated with the Medtronic 670G
Type 1 Diabetes patients treated with the Medtronic 670G at Boston Childrens Hospital
Medtronic 670G insulin pump
* percent of patients who continue to use Medtronic 670G over time
* impact of 670G on glycemic control: hemoglobin A1c, time in range
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medtronic 670G insulin pump
* percent of patients who continue to use Medtronic 670G over time
* impact of 670G on glycemic control: hemoglobin A1c, time in range
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient of Boston Childrens Hospital diabetes program
* deemed to be adequate candidates for hybrid closed loop technology by their diabetes health care team
* patient received Medtronic 670G training at Boston Childrens Hospital
* patient received follow up diabetes care at Boston Childrens Hospital for at least 3 months after starting on the 670G
Exclusion Criteria
5 Years
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston Children's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gregory Goodwin
Senior Associate Physician in Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gregory Goodwin, MD
Role: PRINCIPAL_INVESTIGATOR
Boston Children's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Boston Childrens Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-P00028472
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.